
Frontier IP Group PLC Exscientia rare disease drug discovery collaboration with Rallybio
Frontier IP Group PLC (LON:FIPP), a specialist in commercialising university intellectual property, today noted the following announcement from portfolio company Exscientia, a world leader in artificial intelligence drug discovery, that